PHARMA
GE Healthcare & Takeda Form Alliance For Liver Disease
GE Healthcare's MR elastography technology will aid researchers in non-invasively assessing liver stiffness in the search for new drugs.
Astellas & Harvard Take On Retinitis Pigmentosa
Astellas will fund a study of genetic retinal degenerative disease run by Dr. Constance Cepko from Harvard University.
Takeda Invests In Vaccine Safe Co.
Alfresa's Vaccine Scheduling System helps parents keep track of their children's increasingly complex vaccination schedules.
Takeda Partners With American Therapeutic Accelerator BioMotiv
BioMotiv and Takeda pharmaceutical company enter into a strategic partnership to identify and develop pioneering medical innovations.
First Drug For Dementia With Lewy Bodies Approved
Eisai's Aricept® is the world's first treatment indicated for both Alzheimer's and dementia with Lewy bodies.
ASLAN Commences Taiwan Trials For Gastric Cancer Drug
ASLAN has begun treating its first gastric cancer patients in Taiwan, where 4,000 people are affected by the disease annually.
Luye Acquires Jialin for US$600 Million
Luye Pharma strengthens its position in China's cardiovascular drug market with the US$600 million acquisition of Beijing Jialin Pharmaceutical.
Eisai & Zeria To Develop Gastic Acid Drug
Eisai grants Zeria the right to manufacture E3710, a proton pump inhibitor than can be used to treat gastric acid-related diseases.
South Korean FDA Approval For Green Cross’ Neulapeg®
Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.
